Laparoscopic salpingostomy versus laparoscopic local methotrexate injection in the management of unruptured ectopic gestation.
Zilber U, Pansky M, Bukovsky I, Golan A.
Am J Obstet Gynecol. 1996 Sep;175(3 Pt 1):600-2. doi: 10.1053/ob.1996.v175.a74249.
Reproductive outcome after laparoscopic local methotrexate injection for tubal pregnancy.
Pansky M, Bukovsky J, Golan A, Avrech O, Langer R, Weinraub Z, Caspi E.
Fertil Steril. 1993 Jul;60(1):85-7. doi: 10.1016/s0015-0282(16)56041-5.
Suspected ectopic pregnancy.
Seeber BE, Barnhart KT.
Obstet Gynecol. 2006 Feb;107(2 Pt 1):399-413. doi: 10.1097/01.AOG.0000198632.15229.be.
Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate.
Nieuwkerk PT, Hajenius PJ, Van der Veen F, Ankum WM, Wijker W, Bossuyt PM.
Fertil Steril. 1998 Sep;70(3):518-22. doi: 10.1016/s0015-0282(98)00213-1.
Ectopic pregnancy.
Lehner R, Kucera E, Jirecek S, Egarter C, Husslein P.
Arch Gynecol Obstet. 2000 Feb;263(3):87-92. doi: 10.1007/s004040050001.
Tubal patency after local methotrexate injection for tubal pregnancy.
Pansky M, Bukovsky I, Golan A, Weinraub Z, Schneider D, Langer R, Arieli S, Caspi E.
Lancet. 1989 Oct 21;2(8669):967-8. doi: 10.1016/s0140-6736(89)90966-5.
Systemic methotrexate therapy versus laparoscopic salpingostomy in patients with tubal pregnancy. Part I. Impact on patients' health-related quality of life.
Nieuwkerk PT, Hajenius PJ, Ankum WM, Van der Veen F, Wijker W, Bossuyt PM.
Fertil Steril. 1998 Sep;70(3):511-7. doi: 10.1016/s0015-0282(98)00212-x.
Laparoscopic methotrexate instillation in unruptured tubal pregnancy--is it worthwhile?
Jamal HS, Amarin Z.
J Obstet Gynaecol. 2001 Jul;21(4):402-4. doi: 10.1080/01443610120068644.
Rising beta-hCG titres following laparoscopic injection of methotrexate into unruptured, viable tubal pregnancies.
Fernandez H, Bourget P.
Br J Obstet Gynaecol. 1993 Dec;100(12):1153. doi: 10.1111/j.1471-0528.1993.tb15195.x.
Rising beta-hCG titres following laparoscopic injection of methotrexate into unruptured, viable tubal pregnancies.
Gocze PM.
Br J Obstet Gynaecol. 1993 Dec;100(12):1153-4. doi: 10.1111/j.1471-0528.1993.tb15196.x.
